Llista de publicacions més recents liderades per la Unitat de Memòria de l’Hospital de Sant Pau:
- Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndrome. Lleó, A, Zetterberg, H, Pegueroles, J et al. Nat Commun 2021PMID:34262030
- Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome. Bejanin, A, Iulita, MF, Vilaplana, E et al. JAMA Neurol 2021PMID:34228042
- Epilepsy in Down Syndrome: A Highly Prevalent Comorbidity. Altuna, M, Giménez, S, Fortea, J et al. J Clin Med 2021PMID:34202784
- VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome. Lleó, A, Carmona-Iragui, M, Videla, L et al. Alzheimers Res Ther 2021PMID:34183050
- Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias. Alcolea, D, Delaby, C, Muñoz, L et al. J Neurol Neurosurg Psychiatry 2021PMID:34103344
- Biomarkers in neurological disorders: a fast-growing market. Lleó, A Brain Commun 2021PMID:33977270
- AMYQ: An index to standardize quantitative amyloid load across PET tracers. Pegueroles, J, Montal, V, Bejanin, A et al. Alzheimers Dement 2021PMID:33797846
- Diagnostic Utility of Measuring Cerebral Atrophy in the Behavioral Variant of Frontotemporal Dementia and Association With Clinical Deterioration. Illán-Gala, I, Falgàs, N, Friedberg, A et al. JAMA Netw Open 2021PMID:33704477
- Sex differences in the behavioral variant of frontotemporal dementia: A new window to executive and behavioral reserve. Illán-Gala, I, Casaletto, KB, Borrego-Écija, S et al. Alzheimers Dement 2021PMID:33590953
- Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease. Illán-Gala, I, Lleo, A, Karydas, A et al. Neurology 2021PMID:33199433
- Biphasic cortical macro- and microstructural changes in autosomal dominant Alzheimer's disease. Montal, V, Vilaplana, E, Pegueroles, J et al. Alzheimers Dement 2021PMID:33196147
- Heterozygous APOE Christchurch in familial Alzheimer's disease without mutations in other Mendelian genes. Hernandez, I, Gelpi, E, Molina-Porcel, L et al. Neuropathol Appl Neurobiol 2021PMID:33095930
- Genetic-environmental factors finally assessed together in Parkinson's disease. Clarimón, J J Neurol Neurosurg Psychiatry 2020PMID:32934106
- Cortical microstructure in the amyotrophic lateral sclerosis-frontotemporal dementia continuum. Illán-Gala, I, Montal, V, Pegueroles, J et al. Neurology 2020PMID:32913016
- Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndrome. Belbin, O, Xiao, MF, Xu, D et al. Mol Neurodegener 2020PMID:32807227
- Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis. Dols-Icardo, O, Montal, V, Sirisi, S et al. Neurol Neuroimmunol Neuroinflamm 2020PMID:32669313
- Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests. Benejam, B, Videla, L, Vilaplana, E et al. Alzheimers Dement (Amst) 2020PMID:32613076
- Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Fortea, J, Vilaplana, E, Carmona-Iragui, M et al. Lancet 2020PMID:32593336
- Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders. Delaby, C, Alcolea, D, Carmona-Iragui, M et al. Sci Rep 2020PMID:32514050
- Assessing circular RNAs in Alzheimer's disease and frontotemporal lobar degeneration. Cervera-Carles, L, Dols-Icardo, O, Molina-Porcel, L et al. Neurobiol Aging 2020PMID:32335360
- Atrophy of Basal Forebrain Initiates with Tau Pathology in Individuals at Risk for Alzheimer's Disease. Cantero, JL, Atienza, M, Lage, C et al. Cereb Cortex 2020PMID:31799623
- APP-derived peptides reflect neurodegeneration in frontotemporal dementia. Illán-Gala, I, Pegueroles, J, Montal, V et al. Ann Clin Transl Neurol 2019PMID:31789459
- The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders. Alcolea, D, Clarimón, J, Carmona-Iragui, M et al. Alzheimers Dement (N Y) 2019PMID:31650016
- Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse. Alcolea, D, Pegueroles, J, Muñoz, L et al. Ann Clin Transl Neurol 2019PMID:31464088
- Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: The complex triangle of brain amyloidosis. Carmona-Iragui, M, Videla, L, Lleó, A et al. Dev Neurobiol 2019PMID:31278851
- Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's disease. Morenas-Rodríguez, E, Alcolea, D, Suárez-Calvet, M et al. Sci Rep 2019PMID:31127154
- Nanoscale structure of amyloid-β plaques in Alzheimer's disease. Querol-Vilaseca, M, Colom-Cadena, M, Pegueroles, J et al. Sci Rep 2019PMID:30914681
- Cortical microstructure in the behavioural variant of frontotemporal dementia: looking beyond atrophy. Illán-Gala, I, Montal, V, Borrego-Écija, S et al. Brain 2019PMID:30906945
- Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid. Lleó, A, Núñez-Llaves, R, Alcolea, D et al. Mol Cell Proteomics 2019PMID:33431128